ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,450,106 | -10.3% | 1,343,040 | +1.6% | 1.01% | -6.1% |
| Q2 2023 | $40,639,510 | -14.2% | 1,322,040 | +0.5% | 1.08% | -18.4% |
| Q1 2023 | $47,391,700 | -10.8% | 1,315,340 | -2.1% | 1.32% | -6.8% |
| Q4 2022 | $53,109,911 | -1.6% | 1,343,740 | +0.0% | 1.42% | -13.2% |
| Q3 2022 | $53,975,000 | -4.7% | 1,343,340 | -0.2% | 1.63% | +2.0% |
| Q2 2022 | $56,609,000 | +7.9% | 1,346,540 | 0.0% | 1.60% | +24.7% |
| Q1 2022 | $52,461,000 | -3.7% | 1,346,540 | -1.5% | 1.28% | +2.4% |
| Q4 2021 | $54,496,000 | +30.2% | 1,367,540 | +18.1% | 1.25% | +23.2% |
| Q3 2021 | $41,844,000 | +41.7% | 1,157,840 | +60.8% | 1.02% | +49.3% |
| Q2 2021 | $29,523,000 | – | 720,240 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |